Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 4, Avril 2010
Page(s) 391 - 396
Section M/S revues
DOI https://doi.org/10.1051/medsci/2010264391
Publié en ligne 15 avril 2010
  1. Cooper SA, van der Loeff MS, Taylor GP. The neurology of HTLV-1 infection. Pract Neurol 2009; 9 : 16–26.
  2. Mahieux R, Hermine O. In vivo and in vitro treatment of HTLV-1 and HTLV-2 infected cells with arsenic trioxide and interferon-alpha. Leuk Lymphoma 2005; 46 : 347–55.
  3. Bangham CR. The immune response to HTLV-1. Curr Opin Immunol 2000; 12 : 397–402.
  4. Mesnard JM, Devaux C. Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 Tax protein. Virology 1999; 257 : 277–84.
  5. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007; 7 : 270–80.
  6. Arpin-Andre C, Mesnard JM. The PDZ domain-binding motif of the human T cell leukemia virus type 1 Tax protein induces mislocalization of the tumor suppressor hScrib in T cells. J Biol Chem 2007; 282 : 33132–41.
  7. Gabet AS, Mortreux F, Charneau P, et al. Inactivation of hTERT transcription by Tax. Oncogene 2003; 22 : 3734–41.
  8. Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 2005; 24 : 6047–57.
  9. Gaudray G, Gachon F, Basbous J, et al. The complementary strand of HTLV-1 RNA genome encodes a bZIP transcription factor that down-regulates the viral transcription. J Virol 2002; 76 : 12813–22.
  10. Larocca D, Chao LA, Seto MH, Brunck TK. Human T-cell leukemia virus minus strand transcription in infected T-cells. Biochem Biophys Res Commun 1989; 163 : 1006–13.
  11. Cavanagh MH, Landry S, Audet B, et al. HTLV-I antisense transcripts initiating in the 3’LTR are alternatively spliced and polyadenylated. Retrovirology 2006; 3 : 15.
  12. Murata K, Hayashibara T, Sugahara K, et al. A novel alternative splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J Virol 2006; 80 : 2495–505.
  13. Satou Y, Yasunaga JI, Yoshida M, Matsuoka M. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci USA 2006; 103 : 720–25.
  14. Usui T, Yanagihara K, Tsukasaki K, et al. Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells. Retrovirology 2008; 5 : 34.
  15. Hivin P, Frédéric M, Arpin-André C, et al. Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs. J Cell Sci 2005; 118 : 1355–62.
  16. Hivin P, Arpin-André C, Clerc I, et al. A modified version of a Fos-associated cluster in HBZ affects Jun transcriptional potency. Nucleic Acids Res 2006; 34 : 2761–72.
  17. Basbous J, Arpin C, Gaudray G, et al. HBZ factor of HTLV-I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity. J Biol Chem 2003; 278 : 43620–27.
  18. Thébault S, Basbous J, Hivin P, et al. HBZ interacts with JunD and stimulates its transcriptional activity. FEBS Lett 2004; 562 : 165–70.
  19. Matsumoto J, Ohshima T, Isono O, Shimotohno K. HTLV-1 HBZ suppresses AP-1 activity by impairing both the DNA-binding ability and the stability of c-Jun protein. Oncogene 2005; 24 : 1001–10.
  20. Hivin P, Basbous J, Raymond F, et al. The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies. Retrovirology 2007; 4 : 14.
  21. Lemasson I, Lewis MR, Polakowski N, et al. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J Virol 2007; 81 : 1543–53.
  22. Clerc I, Polakowski N, Andre-Arpin C, et al. An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ. J Biol Chem 2008; 283 : 23903–13.
  23. Yoshida M, Satou Y, Yasunaga J, et al. Transcriptional control of spliced and unspliced HTLV-1 bZIP factor gene. J Virol 2008; 82 : 9359–68.
  24. Landry S, Halin M, Vargas A, et al. Upregulation of human T-cell leukemia virus type 1 antisense transcription by the viral tax protein. J Virol 2009; 83 : 2048–54.
  25. Arnold J, Yamamoto B, Li M, et al. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 2006; 107 : 3976–82.
  26. Li M, Kesic M, Yin H, et al. Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals. J Virol 2009; 83 : 3788–97.
  27. Saito M, Matsuzaki T, Satou Y, et al. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Retrovirology 2009; 6 : 19.
  28. Suemori K, Fujiwara H, Ochi T, et al. HBZ is an immunogenic protein but not a target antigen for HTLV-1-specific cytotoxic T lymphocytes. J Gen Virol 2009; 90 : 1806–11.
  29. Arnold J, Zimmerman B, Li M, et al. Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation. Blood 2008; 112 : 3788–97.
  30. Kuhlmann AS, Villaudy J, Gazzolo L, et al. HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT). Retrovirology 2007; 4 : 92.
  31. Manel N, Kinet S, Kim FJ, et al. GLUT-1 est le récepteur des rétrovirus humains HTLV. Med Sci (Paris) 2004; 20 : 277–9.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.